medigraphic.com

2002, Number 2

<< Back Next >>

Vet Mex 2002; 33 (2)

Is death important for life?

Flores-Pérez FI

Language: English/Spanish
References: 33
Page: 161-172
PDF size: 142.77 Kb.


ABSTRACT

Programmed cell death (apoptosis) is one of the most studied phenomena in the context of biomedical science. The relevance of it is supported by the fact that several diseases which could affect both human beings and animals are caused by alterations of this physiological mechanism of death. In fact, it is proposed in this study that: “Without the existence of programmed cell death, life as we know now, could not be possible”. The aim of this paper is to provide a general overview about programmed cell death, and also to define and show its own regulation. Alterations of programmed cell death, and the relationship with different diseases are also described, as well as the most common techniques to detect programmed cell death.


REFERENCES

  1. 1. Bright J, Khar A. Apoptosis: programmed cell death in health and disease. Biosci Rep 1994;14:677-681.

  2. 2. Hale JA, Smith CA Sutherland LC, Stoneman VE, Longthorne VL, Culhane AC, et al. Apoptosis: the molecular control. Eur J Biochem 1996;236:1-26.

  3. 3. Blackstone NW, Green DR. The evolution of a mechanism of cell suicide. Bioessays 1999;21:84-88.

  4. 4. Coultas L, Strasser A. The molecular control of DNA damage-induced cell death. Apoptosis 2000;5:491-507.

  5. 5. Evan G, Littlewood T. A matter of life and cell death. Science1988;281:1317-1322.

  6. 6. Kaufmann HS. Apoptosis: pharmacological implications and therapeutic opportunities. San Diego (Ca): Academic Press, 1997.

  7. 7. Kerr JFR, Willie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide -ranging implications in tissue kinetics. Br J Cancer 1972;26:239.

  8. 8. Milligan CE, Schwartz LM. Programmed cell death during development of animals. In:, editors. Cellular aging and cell death. New York: John Wiley & Sons, 1996:181-208.

  9. 9. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1988;281:1305-1308.

  10. 10. Tomei LD, Cope OF. Apoptosis: the molecular basis of cell death. New York: Cold Spring Harbor Press, 1991.

  11. 11. Arends MJ, Morris RG, Wyllie AH. Apoptosis: the role of the endonuclease. Am J Pathol 1990;136:593-608.

  12. 12. Thornberry AN, Lazebnik Y. Caspases: enemies within. Science 1988;281:1312-1316.

  13. 13. Zhivotovsky B, Samali A, Gahm A, Orrenius S. Caspases: their intracellular localization and translocation during apoptosis. Cell Death Differ 1999;6:644-651.

  14. 14. Utz PJ, Anderson P. Life and death decisions: regulations of apoptosis by proteolysis of signaling molecules. Cell Death Differ 2000;7:589-602.

  15. 15. Wride MA. Minireview: apoptosis as seen through a lens. Apoptosis 2000;5:203-209.

  16. 16. Adams MJ, Suzanne C. The Bcl-2 protein family: arbiters of cell survival. Science 1998;281:1322-1326.

  17. 17. Friedberg CE, Walker GC, Siede W. DNA repair and mutagenesis. Washington (DC): American Society of Microbiology Press, 1995.

  18. 18. Green D, Reed JC. Mitochondria and apoptosis. Science 1988;281:1309-1312.

  19. 19. Kroemer G, Reed J. Mitochondrial control of cell death. Nature 2000;6:513-519.

  20. 20. Simon HU, Haja-Yehia A, Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 2000;5:415-418.

  21. 21. Yakes MF, Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Nat Acad Sci 1997;94:514-519.

  22. 22. Arrowsmith CH. Structure and function in the p53 family. Cell Death Differ 1999;6:1169-1173.

  23. 23. Bendi A, Mookerjee B. Biological significance and molecular mechanisms of p53-induced apoptosis. Apoptosis 1988;3:224-237.

  24. 24. Burns FT, El-Deiry WS. The p53 pathway and apoptosis. J Cell Phys 1999;181:231-239.

  25. 25. Geske FJ, Liberman R, Strange R, Gerschenson LE. Early stages of p53-induced apoptosis are reversible. Cell Death Differ 2001;8:182-191.

  26. 26. Wani MA, Zhu QZ, El-Mahdy M, Wani AA. Influence of p53 tumor suppressor protein on bias of DNA repair and apoptotic response in human cells. Carcinogenesis 1999;20:765-772.

  27. 27. Fisher DE. The p53 tumor suppressor: critical regulator of life & death in cancer. Apoptosis 2001;6:7-15.

  28. 28. Walker RD, Bond JP, Tarone RE, Harris CC, Makalowski W, Boguski MS et al. Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features. Oncogene 1999;19:211-218.

  29. 29. Zangmeister-Wittke U, Simon HU. Apoptosis-regulation and clinical implications. Cell Death Differ 2001;8:537-544.

  30. 30. Barber GN. Host defence, viruses and apoptosis. Cell Death Differ 2001;8:113-126.

  31. 31. Roshal M, Zhu Y, Planelles V. Apoptosis in AIDS. Apoptosis 2001;6:103-116.

  32. 32. Lorenz HM, Herrmann M, Winkler T, Gaipl U, Kalden R.J. Role of apoptosis in autoimmunity. Apoptosis 2000;5:443-449.

  33. 33. Ormerod MG. Flow cytometry: a practical approach. 2nd ed. Oxford (UK): Oxford University Press, 1994.




2020     |     www.medigraphic.com